TruthArchive.ai - Related Video Feed

The speakers discuss the potential dangers of new technologies being developed. They mention the possibility of vaccines that can change DNA and be remotely updated to control human genomes. They also talk about the creation of life in cells and the ability to program them to produce desired products. The speakers highlight the concept of designer receptors that can be remotely controlled and inserted into living systems. They express concerns about the impact these technologies could have on human thoughts and actions.

The speaker discusses the use of mRNA in food and mentions a presentation about genetically engineering mosquitoes to deliver vaccines through mosquito bites. They mention that the Gates Foundation is funding this research, although they don't have proof of its viability. The speaker clarifies that they are not suggesting that the mosquitoes are currently injecting anyone with anything, but they have evidence that efforts are being made to enable mosquito injections.

mRNA vaccines, like the ones developed for the pandemic, have brought attention to the potential of gene and cell therapy. Previously, if we had asked the public if they would be willing to receive such treatments, the majority would have refused. However, the pandemic has changed people's perspectives and made them more open to innovative approaches in healthcare.

The speakers discuss the potential dangers of new technologies being developed. They mention the possibility of vaccines that can change DNA and be remotely updated to control human genomes. They also talk about the creation of life in cells and the ability to program them to produce desired products. The speakers highlight the concept of designer receptors that can be remotely controlled to affect the way a person thinks and acts. These advancements raise concerns about complete control over humanity.

Technology is being rapidly advanced and implemented in humans, particularly messenger RNA vaccines. These advancements are being fast-tracked, and it's important to acknowledge that our food species will also be affected by these vaccines.

We are discussing regulation and the use of CRISPR to reduce mosquito populations and combat malaria. We are working with African countries on necessary trials. It will take time to get approvals, but the potential to eliminate disease locally is promising. Malaria is transmitted by mosquitoes, and we are demonstrating this by releasing some in the auditorium. Everyone should understand the impact, not just the poor.

The speaker states that mRNA in food is a critical issue, but also highlights the potential for transgenic mosquitoes to deliver vaccines via saliva. They reference a presentation about producing a transgenic mosquito as a "flying syringe" to deliver protective vaccines. The speaker claims the Gates Foundation is funding genetic engineering of mosquitoes with the intention of using mosquito bites for vaccination. While they don't have definitive proof of its viability, they assert that this research is underway. The speaker clarifies they are not claiming current mosquitoes are injecting people with anything. However, they state they have indisputable evidence that efforts are being made to enable mosquitoes to inject people with substances in the future.

Transcript excerpt from January 1999 discusses a subtitle question about how genetic engineering will change us in the next century. The speakers present the following claims: 'This is January 1999. The statement in the subtitle is, How Genetic Engineering Will Change Us When? In the Next Century.' 'Statin drugs will shut down the absorption of CoQ10.' 'And that's why what Doctor. Group was saying, we need to we're doing this because this conversation has to start now.' 'Because one way direction is giving up your power to somebody else to fix you. The other way is you taking your own power to fix yourself.'

Two years ago, most people would have refused gene or cell therapy, but the pandemic has changed that. mRNA vaccines are a prime example of this shift towards innovation in healthcare.

January 1999 framing begins with the subtitle: "How Genetic Engineering Will Change Us When? In the Next Century." The discussion notes a claim: "Statin drugs will shut down the absorption of CoQ10." It continues with "And that's why what Doctor. Group was saying, we need to we're doing this because this conversation has to start now." The speaker then contrasts personal agency: "Because one way direction is giving up your power to somebody else to fix you. The other way is you taking your own power to fix yourself." The exchange centers on biotechnology's potential impact and a push to initiate the public conversation about personal empowerment versus external fixes.

The speaker suggests that prior to the pandemic, a survey asking the public about willingness to receive gene or cell therapy would have likely resulted in a 95% refusal rate. They believe the pandemic has opened people's minds to innovation in a way that was previously impossible, using mRNA vaccines as an example.

A speaker discusses genetically modified organisms (GMOs) and the debate surrounding their safety, mentioning a petition signed by 17 Nobel laureates asserting their safety. The speaker says that while millions have consumed GMOs without apparent harm, the context is important. The speaker explains that GMOs are often engineered to resist glyphosate, and glyphosate is used heavily. Glyphosate is described as an antibiotic, patented for antibiotic use, that kills microbiota around plants. The speaker claims that glyphosate is the most prescribed antibiotic on Earth, especially in rice farming, and that the consequences of its widespread use are unknown.

We are in a digital and scientific revolution, hacking the software of life with mRNA. Our body is made of organs, organs of cells, and in each cell is messenger RNA transmitting DNA information to proteins. This "operating system" can be altered to impact diseases like the flu and cancer. For instance, instead of injecting virus proteins for a flu vaccine, mRNA instructions can teach the body to make its own protection. This mRNA technology has vast potential for disease prevention and treatment.

Obesity rates in America have increased eightfold since the speaker's birth, rising from 5% to 42%. This increase is not attributable to genetic mutations. Even if all genes potentially impacting hunger, weight, metabolism, and obesity risk were corrected, the maximum weight loss would only be 22 pounds. This would not solve the obesity problem or enable the 50-100 pound weight loss needed by many Americans. Therefore, obesity is not primarily a genetic issue.

The panel discusses replication (replicon) vaccines and their potential dangers, focusing on how they differ from conventional messenger RNA (mRNA) vaccines and what new risks might emerge as this technology develops. Key points and concerns raised - Replicon vaccines concept and fundamental differences - Replicon vaccines use replication-capable genetic material, so the embedded genetic information not only makes antigen proteins but also multiplies inside the cell. They are described as having both constitutive function (the ability to make proteins) and, crucially, the capacity to replicate, which distinguishes them from traditional, non-replicating mRNA vaccines. - It is explained that replication introduces additional mutation and recombination opportunities, because the RNA genome is copied more than once, and the process can produce variants that differ from the original design. - Central dogma exceptions and viral biology - The speakers explain that while the central dogma (DNA → RNA → protein) generally governs biology, some viruses violate this, with RNA viruses that replicate via RNA-dependent replication and even some reverse-transcribing retroviruses that convert RNA to DNA and integrate into genomes. This context is used to frame why replicon vaccines could behave unpredictably. - Potential risks of replication and spread - A core concern is that the replicon approach might allow the vaccine genome to spread beyond the initial target cells, potentially reaching other cells and tissues, or even spreading to other people via exosomes or other means. Exosomes can transport DNA, RNA, and proteins between cells; thus, the replicon genome could in theory be disseminated. - The possibility of homologous or heterologous recombination between replicon genomes and wild-type viruses could yield new variants. The panel emphasizes the difficulty of controlling such recombination in a living system. - Specific material and design considerations - The use of viral components like spike protein genes in replicon vaccines raises concerns about how these proteins might mutate or recombine during replication, potentially altering antigen presentation or safety. - A concern is raised about the lack of repair mechanisms in RNA replication (as opposed to DNA replication), which could make error rates higher and lead to unpredictable changes. - The panel notes that current replicon vaccine designs (including those using alphavirus backbones) inherently carry high mutation and recombination risk, and that the replicating systems may encounter unpredictable evolutionary dynamics inside the human body. - Safety signals and clinical anecdotes - The speakers cite cases of adverse events temporally associated with vaccines, including vascular inflammation and thrombosis, stroke-like events, and myocarditis, to illustrate that immune responses to vaccines can be complex and occasionally severe. They emphasize that such observations do not establish causality, but argue they warrant careful scrutiny. - There are references to cases of acute vascular and neural complications following repeated vaccination, and to broader immune dysregulation phenomena, including IGG4-related disease and immune dysregulation syndromes that can involve multiple organs. - One example concerns a patient who developed sudden limb problems after the third dose, requiring surgery; another describes myocardial involvement after multiple doses and subsequent inflammatory sequelae. - DNA contamination and analytical findings - Kevin McKernan’s analysis of certain Japanese CoronaVac vaccines is cited: both DNA contamination and the presence of SV40 promoter elements were detected in some vaccine lots, with DNA amounts exceeding some regulatory benchmarks in at least one case. The concern is that DNA contamination, or the presence of promoter sequences, could influence integration or expression in unintended ways. - It is noted that vaccines using lipid nanoparticles can potentially deliver nucleic acids into cells; in the presence of exons or promoter sequences, there could be unintended cellular uptake and expression. - Implications for public health and policy - The panel underscores the need for caution, thorough investigation, and long-term observation of any replication-based vaccine platform before broad deployment. There is a call to evaluate risks, monitor long-term outcomes, and consider the possibility that replication-competent constructs could drive unforeseen evolutionary dynamics within hosts or communities. - There is contention about how information is communicated to the public, with particular emphasis on avoiding misinformation while ensuring that scientific uncertainties are transparently discussed. - Broader scientific context and forward-looking stance - The speakers discuss how the field’s approach to gene-based vaccines is evolving rapidly, and they stress that the compatibility of replicon systems with human biology is not yet fully understood. - They frame their discussion as not merely about current vaccines but about the trajectory of vaccine platforms: if replication-based or self-dispersing systems prove too risky or unpredictable, the prudent path might be to favor conventional, non-replicating strategies until safety, efficacy, and containment of unintended spread are more firmly established. Closing and takeaways - The session closes with emphasis on careful evaluation of replicon vaccines, awareness that viral genetics can behave differently in humans than in theory, and a call for continued discussion, independent verification, and transparent communication as the technology develops. - Throughout, speakers acknowledge the complexity of immune responses to vaccines, the potential for unexpected adverse events, and the importance of safeguarding public health while advancing vaccine science.

The speakers discussed the possibility of using gene editing to solve hair loss and enhance physical attributes. They stated that delivering gene therapies to specific cells is improving, with sickle cell anemia research being the most advanced, using a single CRISPR knockout. This could potentially be done on someone already born, though it's easier at the embryo stage. One speaker envisions a future where gene editing allows people to alter their appearance and intelligence, referencing plastic surgery trends like South Korean eye surgery and GLP-1s. The other speaker likened this to a "eugenics world" and "playing God."

Speaker 0: I think what a lot of people aren't really familiar with is the bioengineering aspect of this, and we only need to look to this recently published headline from the Daily Mail, which was resurfaced, declassified CIA files that revealed a chilling blueprint to manipulate Americans' minds through covert drugging with vaccines. And it's not just vaccines that was in that blueprint. It's also the food, the water supply, pretty much altering our state of mind and our biology through all of these methods. And this is going back all the way to the fifties. One can only imagine how far they've come now, but you've been digging into this, and you have a bit of an idea as to how far they've come. To us about your latest research. Speaker 1: So you're absolutely right. And this has been, you know, a slow progression. Nothing is just being, you know, introduced new. I mean, it the technology has advanced, but it's been going on for decades decades, hundreds of years. And when you think about pharmaceuticals, the the apparatus of pharmaceuticals, they are all they it is medicinal chemistry, which is synthetic materials, synthetic biology, engineered bacteria, yeasts, molds, and all of those things like you just said. We have we are being assaulted with these these materials, which are now considered devices, you know, with the manipulated EMF and frequencies. And all of those are to exactly what you just said, weaken the system. And really this pro this slow progression of a we're in the midst of a forced evolution to become providers of a synthetic material, hybrid synthetic material. So we'll continue to produce as we do because the humanity's biological systems are by design meant to thrive and recycle and and repurpose themselves, but to survive. And so we accept these synthetic materials, and we and our body slowly begin to make accommodations to those mutations, natural mutations, but also so much of these so much of the synthetic material is coded to go in and trigger a mutation or to forcibly cause a mutation. So we literally are walking around. I mean, all of us, and it goes from the tiny little mushroom that's growing in the woods to, you know, aquatic life to every single biological electrical system, the nervous system, you know, is based on frequency. It's based on electricity. And so that is that's what's being attacked is the nervous system and the immune systems of every living being. Speaker 0: Now you're talking about some very important things here, Lisa. You've sent me this article from Medium titled the synthetic nervous system, a blueprint for physical AI. And in this article, it talks about how for the past decade, AI has lived primarily in a box, but now, our, you know, our interaction with AI has been linguistic and digital. We've cracked the code apparently, completely on generative AI, unlocking the ability to, listen to this, manipulate symbols, pixels, and code at scale, but we're now entering a far more complex epoch, the era of physical AI. And they are talking about the transition from AI that thinks to AI that acts. So they're saying the intelligence behind humanoid robots. They also give, you know, autonomous systems and things of this nature. My concern is that their plan stated goal is that they want humans to integrate with AI. This is something that even Elon Musk itself has said we need to do in order to stay relevant. And your research shows that they're already in the process of doing that. Talk to us a little bit about that. Speaker 1: Yes. And probably have. We and and, you know, I think that life as we know it will fairly stay the same because what the integration is through, and you've heard of this, is the digital twin. You know, assigning each of us a representative in the AI ecosystem, ecosystem, which which is is a a digital twin. But that digital twin is able to function and, perform because it is it is based off of your data, your biological data, your, that they are going in and removing and stealing through the infiltrators and facilitators that is vaccines, bioengineered foods, bioengineered bacteria. The, you know, the pharmaceutical industry is the perfect setup, and it's only one of one setup that goes in, and now these are all synthetic material devices. They work off of Wi Fi. They're software platforms, and they are all digital. And they are being monitored by the Department of Energy, HHS, MITRE now, these private companies and private oligarch, you know, tech companies that all have access to our free our our inner, you know, biological data DNA and and everything. And so that the AI platform, in order for it to succeed and for its longevity, there has to be a cohesive connection between humanity because we are the fuel that is going to feed that AI ecosystem. And it cannot it it's not gonna be one or the other. It has to work cohesively, and and they have to be joined. And how the the joining of those literally is through an infiltration system, which is primarily vaccines and engineered pathogens.